DEXMDERM

Welcome to the Brand page for “DEXMDERM”, which is offered here for Transdermal patches for use in the treatment of attention deficit hyperactivity disorder, anxiety insomnia, or withdrawal syndromes; transdermal patches for use in the management of pain; and transdermal patches for use in providing sedation; pharmaceutical preparations, topical preparations for use in the treatment of attention deficit hyperactivity disorder; pharmaceutical preparations, topical preparations for use in the treatment of anxiety; pharmaceutical preparations, topical preparations for use in the treatment of insomnia; pharmaceutical preparations, topical preparations for use in the treatment of withdrawal syndromes; topical preparations for use in the management of pain; and topical preparations for use in providing sedation;.

Its status is currently believed to be active. Its class is unavailable. “DEXMDERM” is believed to be currently owned by “Teikoku Pharma USA, Inc.”


Owner:
TEIKOKU PHARMA USA, INC.
Owner Details
Description:
Transdermal patches for use in the treatment of attention deficit hyperactivity disorder, anxiety insomnia, or withdrawal syndromes; transdermal patches for use in the management of pain; and transdermal patches for use in providing sedation; Pharmaceutical preparations, topical preparations for use in the treatment of attention deficit hyperactivity disorder; Pharmaceutical preparations, topical preparations for use in the treatment of anxiety; Pharmaceutical preparations, topical preparations for use in the treatment of insomnia; Pharmaceutical preparations, topical preparations for use in the treatment of withdrawal syndromes; topical preparations for use in the management of pain; and topical preparations for use in providing sedation;
Categories: TRANSDERMAL PATCHES USE